Início › Tumores Cerebrais › Califórnia › Los Angeles
Ensaios clínicos de Tumores Cerebrais em Los Angeles, CA
16 estudos para Tumores Cerebrais estão buscando participantes em locais em Los Angeles e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecrutandoFase 2
- Cedars-Sinai Medical Center, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecrutandoFase 1/2
- University of Southern California, Los Angeles
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
RecrutandoFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecrutandoFase 1/2
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecrutandoFase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RecrutandoFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RecrutandoFase 1/2
- California Research Institute, Los Angeles
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RecrutandoFase 2
- Univ. of California Los Angeles, Los Angeles
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
RecrutandoFase 2
- Children's Hospital Los Angeles, Los Angeles
REMASTer: REcurrent Brain Metastases After SRS Trial
Recrutando
- UCLA, Los Angeles
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RecrutandoFase 1/2
- University of California Los Angeles, Los Angeles
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
RecrutandoFase 1
- Children's Hospital Los Angeles, Los Angeles
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
RecrutandoFase 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
Recrutando
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecrutandoFase 3
- USC / Norris Comprehensive Cancer Center, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RecrutandoFase 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Ensaios de Tumores Cerebrais em outras cidades
- Houston, TX35 estudos
- Boston, MA28 estudos
- New York City, NY25 estudos
- Washington, DC20 estudos
- Miami, FL15 estudos
- Durham, NC14 estudos
- St. Louis, MO12 estudos
- Rochester, MN11 estudos
- Chicago, IL11 estudos
- Cleveland, OH11 estudos
- Baltimore, MD11 estudos
- Columbus, OH11 estudos
Outros estudos em Los Angeles
- Câncer de Pulmão de Não Pequenas Células87 estudos
- Câncer (todos os tipos)74 estudos
- Câncer de Mama73 estudos
- Câncer de Próstata61 estudos
- Câncer Colorretal59 estudos
- Câncer Metastático57 estudos
- Câncer de Ovário50 estudos
- Câncer de Pulmão45 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço42 estudos
- Câncer de Pâncreas35 estudos
- Câncer Endometrial34 estudos
- Melanoma34 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.